Brought to you by 
Inhale acquires Bradford Particle Design for $200mm
31 May 2001
Executive Summary
Leveraging its technological strength in powders and inhalation, and seeking to broaden its product base, Inhale Therapeutic Systems is acquiring UK company Bradford Particle Design (engineers particles for drug delivery) for about $210mm---$190mm in stock (about 3.75mm shares) and $20mm in cash, or about 23 times its 2000 sales.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inhale acquires Bradford Particle Design for $200mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice